← Browse by Condition
Medical Condition
rheumatoid arthritis
Total Trials
18
Recruiting Now
18
Trial Phases
Phase 2, Phase 4, Phase 1
NCT07126431
Recruiting
Prospective Cohort Study on Refractory Rheumatoid Arthritis
Enrollment
200 pts
Location
China
Sponsor
Peking University Third Hospit...
NCT04134169
Recruiting
Long-term Observational Study to Evaluation the Safety of FURESTEM-RA Inj(K0202)
Enrollment
28 pts
Location
South Korea
Sponsor
Kang Stem Biotech Co., Ltd.
NCT06299917
Recruiting
WORK-ON Vocational Rehabilitation for People with Inflammatory Arthritis
Enrollment
56 pts
Location
Denmark
Sponsor
The Danish Center for Expertis...
NCT06567470 Phase 2
Recruiting
A Study With CIT-013 in RA Patients
Enrollment
88 pts
Location
Belgium, Germany, Ne...
Sponsor
Citryll BV
NCT06579222
Recruiting
Comorbidity Management in Rheumatic Disease.
Enrollment
199 pts
Location
Canada
Sponsor
Western University, Canada
NCT06146972 Phase 4
Recruiting
Efficacy Study of Iguratimod Combined With Tofacitab in Patients With RF Positive/Negative Rheumatoid Arthritis
Enrollment
117 pts
Location
China
Sponsor
Yanfeng Hou
NCT06235645
Recruiting
dEtection of rheumAtoid aRthritis - Interstitial Lung dIseasE by Thoracic ultRasound
Enrollment
280 pts
Location
France
Sponsor
University Hospital, Tours
NCT06593041
Recruiting
ROLE of PLATELETS in the PATHOPHYSIOLOGY of SYSTEMIC LUPUS
Enrollment
450 pts
Location
France
Sponsor
University Hospital, Strasbour...
NCT07180537
Recruiting
Creating Health Course Study for People With Rheumatological Conditions
Enrollment
200 pts
Location
United States
Sponsor
Terry L. Wahls
NCT06572696
Recruiting
Ultrasonographic Evaluation of Asymptomatic Shoulder Joint Pathologies in Rheumatoid Arthritis Patients
Enrollment
60 pts
Location
Turkey (Türkiye)
Sponsor
Fatih Sultan Mehmet Training a...
NCT06581562 Phase 1
Recruiting
Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases.
Enrollment
30 pts
Location
United States
Sponsor
IRIS Research and Development,...
NCT03816345 Phase 1
Recruiting
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
Enrollment
300 pts
Location
United States, Canad...
Sponsor
National Cancer Institute (NCI...
NCT06767618
Recruiting
Investigation of Upper Extremity Functions in Patients With Rheumatoid Arthritis
Enrollment
60 pts
Location
Turkey (Türkiye)
Sponsor
Kirsehir Ahi Evran Universites...
NCT03895879 Phase 4
Recruiting
Use of Tocilizumab Drug Levels to Optimize Treatment in RA
Enrollment
98 pts
Location
Netherlands
Sponsor
Reade Rheumatology Research In...
NCT04985435 Phase 4
Recruiting
Better After CHoosing. Randomly Allocated or Patient Preference Based Treatment With Filgotinib or TNFi in RA (BACH)
Enrollment
100 pts
Location
Netherlands
Sponsor
R.Bos
NCT07052032 Phase 1
Recruiting
An Open-label Study of CND261 in Seropositive Rheumatoid Arthritis
Enrollment
47 pts
Location
Georgia, Moldova, Ne...
Sponsor
Candid Therapeutics
NCT07100938 Phase 2
Recruiting
A Study Investigating the Efficacy and Safety of BGB-45035 Versus Placebo in Adults With Moderate to Severe Active Rheumatoid Arthritis
Enrollment
90 pts
Location
China
Sponsor
BeiGene
NCT06972446 Phase 2
Recruiting
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
Enrollment
180 pts
Location
United States, Canad...
Sponsor
AbbVie